Prioritization schema for immunotherapy clinical trials in glioblastoma

Background: Emerging immunotherapeutic strategies for the treatment of glioblastoma (GBM) such as dendritic cell (DC) vaccines, heat shock proteins, peptide vaccines, and adoptive T-cell therapeutics, to name a few, have transitioned from the bench to clinical trials. With upcoming strategies and de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Hodges, Tiffany R., Ferguson, Sherise D., Caruso, Hillary G., Kohanbash, Gary, Zhou, Shouhao, Cloughesy, Timothy F., Berger, Mitchel S., Poste, George H., Khasraw, Mustafa, Ba, Sujuan, Jiang, Tao, Mikkelson, Tom, Yung, W.K. Alfred, de Groot, John F., Fine, Howard, Cantley, Lewis C., Mellinghoff, Ingo K., Mitchell, Duane A., Okada, Hideho, Heimberger, Amy B.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4938323/
https://ncbi.nlm.nih.gov/pubmed/27471611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1145332
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados